ahlam1399
03-29-2016, 04:33 PM
India?s Lupin says it sees ** supply disruption at plant despite FDA observations
MUMBAI (Reuters) - Lupin Ltd, India's third-largest drugmaker, said on Tuesday it did **t expect any disruption to supply from its main manufacturing plant despite what it called mi**r observations made by the U.S. Food and Drug Administration after an audit.
http://i1.wp.com/reuters.us.feedsportal.com/c/35217/f/654207/s/4e92f49b/sc/19/mf.gif?resize=1%2C1http://feeds.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/healthNews?a=lYtS7EeBaU8:laF6Ej30k2w:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/healthNews?i=lYtS7EeBaU8:laF6Ej30k2w:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/healthNews?a=lYtS7EeBaU8:laF6Ej30k2w:F7zBnMyn0Lo) http://feeds.feedburner.com/~ff/reuters/healthNews?i=lYtS7EeBaU8:laF6Ej30k2w:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/healthNews?a=lYtS7EeBaU8:laF6Ej30k2w:V_sGLiPBpWU)
http://feeds.feedburner.com/~r/reuters/healthNews/~4/lYtS7EeBaU8
MUMBAI (Reuters) - Lupin Ltd, India's third-largest drugmaker, said on Tuesday it did **t expect any disruption to supply from its main manufacturing plant despite what it called mi**r observations made by the U.S. Food and Drug Administration after an audit.
http://i1.wp.com/reuters.us.feedsportal.com/c/35217/f/654207/s/4e92f49b/sc/19/mf.gif?resize=1%2C1http://feeds.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/healthNews?a=lYtS7EeBaU8:laF6Ej30k2w:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/healthNews?i=lYtS7EeBaU8:laF6Ej30k2w:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/healthNews?a=lYtS7EeBaU8:laF6Ej30k2w:F7zBnMyn0Lo) http://feeds.feedburner.com/~ff/reuters/healthNews?i=lYtS7EeBaU8:laF6Ej30k2w:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/healthNews?a=lYtS7EeBaU8:laF6Ej30k2w:V_sGLiPBpWU)
http://feeds.feedburner.com/~r/reuters/healthNews/~4/lYtS7EeBaU8